Champions Biotechnology Reports Fiscal 2008 Full-Year Financi... ( ARLINGTON VA. July 30 /- Champion...)

Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results

Date:7/30/2008

ARLINGTON, VA., July 30 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2008. Full details of the Company's financial results are available in the Company's Form 10-KSB available at http://www.championsbiotechnology.com.

For the fiscal year ended April 30, 2008 the Company's operating revenue was $1,399,940 as compared to $0.00 for the fiscal year ended April 30, 2007. The Company commenced its operations in the biotechnology business in January 2007 and as a result only had four months of meaningful operations in the fiscal year ended April 30, 2007. The Company generated its revenue in FY 2008 from its Personalized Oncology services which assists physicians by providing information that may enhance personalized treatment options for their cancer patients.

For the fiscal year ended April 30, 2008 general and administrative expenses of $703,176 were incurred compared to $170,058 in FY 2007. The increase was due to the additional expenses associated with beginning operations as a biotechnology company. The Company spent $199,743 on research and development in FY 2008 to grow its Biomerk Tumorgraft(TM) preclinical platform as compared to $0.00 in the prior year period.

For the year ended April 30, 2008 the Company reported net income of $35,698 and earnings per share of $0.00 compared to a net loss of $170,058 and loss of $0.01 per share for the comparable period one year ago.

The Company's cash position on April 30, 2008 was $3,709,136 compared to $3,758 on April 30, 2007. In FY 2008, the net cash provided by operating activities was $792,404. In FY 2007, the net cash used in operating activities was $78,475. The Company's work
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
3. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
4. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
7. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
8. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
9. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
10. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
11. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery

Post Your Comments:

(Date:5/22/2013)... 22, 2013 Alton Housing Authority was hit ... 2013 said that their presence has already caused the ... sufferers avoid such big spending, My Cleaning Products shared a ... It was said in the report that to clear the ... Apart from that, its employees also attended a mandatory training ...

(Date:5/22/2013)... Moderna Therapeutics, the pioneering company developing messenger RNA ... in vivo production of therapeutic proteins, announced ... join Moderna in early July as its first Chief ... leader in the design and implementation of information systems ... translation, clinical operations and commercial preparedness. John has also ...

(Date:5/21/2013)... Belmont, MA (PRWEB) May 21, 2013 ... complete tracking to reporting eLearning solution using Tin ... report and dashboard tool. CLD is a leading ... biotech, and medical device companies worldwide. , ... tracking standard that helps learners and trainers more ...

(Date:5/21/2013)... 2013 The congress of the ... is the biggest congress in Europe ... participants are in Istanbul to ... New pioneering studies have been presented: / ... ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" By ...

Breaking Biology Technology:Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2 Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2 Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3 CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2 CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3 ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2 ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3

[0] Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products [0] Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer [0] CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard [0] ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials

... 2009 Highlights:- GAAP diluted EPS increased 16.0 percent ... EPS, excluding $0.05 in amortization of intangible assets ... $0.63 from $0.55 in first-quarter 2008- Total net ... billion- Specialty pharmacy revenues increased 21.0 percent to ...

... - Increases Accessibility to ... Elsevier, the world,s leading publisher of scientific, technical, ... ten new eBook,Specialty Collections have launched on MD ... This launch provides online availability,of market-leading specialty content ...

... experts listed in the Trusted LASIK Surgeons directory ... at the recently concluded American Society of Cataract ... San Francisco, California. Dr. Randy Epstein, Dr. ... Dr. R. Wayne Bowman, Dr. Shachar Tauber, and ...

Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 Elsevier Launches Ten New eBook Specialty Collections on MD Consult Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting

(Date:5/20/2013)... MINNEAPOLIS/ST. PAUL (MAY 20, 2013) University of Minnesota ... of Minnesota, in partnership with the University,s Brain Tumor ... peripheral nerve sheath tumors (MPNST) that allow them to ... of cancer. , The research was published this week ... the Sleeping Beauty transposon method, researchers in the lab ...

(Date:5/20/2013)... grant will help establish the Center for Advanced Research ... of Illinois at Urbana-Champaign and Worcester Polytechnic Institute (WPI) ... research in drying moist, porous materials such as food ... products; textiles; and biopharmaceuticals," said Hao Feng, a U ... and the Illinois site director. , According to Feng, ...

(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...

Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2 NSF approves planning grant for Center for Advanced Research in Drying 2 Blame your parents for bunion woes 2

[0] U of M researchers develop model for better testing, targeting of MPNST [0] NSF approves planning grant for Center for Advanced Research in Drying [0] Blame your parents for bunion woes

... available in Chinese on EurekAlert! Chinese . ... led by the University of Melbourne and BGI, has sequenced ... pig. This collaborative study, published online in the international journal ... community and paves the way for the development of new ...

... from VTT Technical Research Centre of Finland suggests ... microbial diversity of the Clostridium leptum subgroup, elevated ... In collaboration with the DIPP - Finnish Type ... previously found that specific metabolic disturbances precede early ...

... in German . The ability to dream ... images and emotions that we experience so intensively when we dream ... has not been possible to measure dream content. Max Planck scientists ... succeeded, for the first time, in analysing the activity of the ...

Cached Biology News:BGI reports pig parasite's genomic sequence provides new clues for parasitic diseases research 2 VTT identified specific bacteria which precede autoimmune diabetes 2 Scientists measure dream content for the first time 2

BGI reports pig parasite's genomic sequence provides new clues for parasitic diseases research VTT identified specific bacteria which precede autoimmune diabetes Scientists measure dream content for the first time

... lowest priced, full ring small animal imaging ... the microPET R4 low retail price, it ... categories; count rate performance, energy resolution, timing ... dedicated small animal PET (Positron Emission Tomography) ...

... versatile liquid handling platforms and flexible robotic ... of life science applications.The Freedom EVO platform ... 100, 150 and 200 cm), giving all ... will advance with their application needs. ...

...

... microPET 220 utilizes utilizies CTI ... leading to superior resolution, sensitivty, and ... the user the flexibility to image ... iamge quality., microPET is a dedicated ...

Biology Products:

microPET R4 from CTI Molecular Imaging, Inc.Freedom EVO 75 from Tecan REC. PROTEIN G from Invitrogen microPET Focus 220 from CTI Molecular Imaging, Inc.